Gonadotropin - PowerPoint PPT Presentation

1 / 46
About This Presentation
Title:

Gonadotropin

Description:

Title: PowerPoint Presentation Author: Administrator Last modified by. Created Date: 1/1/1601 12:00:00 AM Document presentation format: Presentazione su schermo (4:3) – PowerPoint PPT presentation

Number of Views:450
Avg rating:3.0/5.0
Slides: 47
Provided by: fertility3
Category:

less

Transcript and Presenter's Notes

Title: Gonadotropin


1
Seconda Università degli Studi di Napoli
Seconda Università degli Studi di Napoli
Dipartimento di Scienze della Vita
SUNfert
  • Gonadotropins
  • Bioactivity

Fertility Center Cardito
Dr. Vincenzo Volpicelli
2
Gonadotropins
  • FSH, LH, HCG
  • glycoproteins
  • dimers a, ß (two peptide chain)
  • a chain aspecific
  • ß chain specific (provides specificity for
    receptor interaction)

Glycoproteins are proteins that contain
oligosaccharide chains covalently attached to
their side-chains.
An oligosaccharide is a saccharide polymer
containing a small number (typically three to
ten) of component sugars, also known as simple
sugars.
3
(No Transcript)
4
FSH
  • heterodimeric hormone
  • 92 amino acids a-chain
  • 111 amino acids ß-chain

The half-life of FSH is 3-4 hours
Various types of FSH exist according to their
sialic acid content
Ben-Rafael Z, Levy T, Schoemaker J. 1995
Pharmacokinetics of follicle-stimulating hormone
clinical significance. Fertil Steril. 63689700
5
LH
  • The gene for the alpha subunit is located
  • on chromosome 6q12.21.
  • The luteinizing hormone beta subunit gene is
    localized in the LHB/CGB gene cluster on
    chromosome 19q13.32

6
LH/HCG bioactivity
  • LH HCG the same amino acids in sequence
  • LH HCG both stimulate the same receptor
  • the hCG ß-subunit contains an additional 24 amino
    acids,
  • both hormones differ in the composition of their
    sugar moieties.
  • The different composition of these
    oligosaccharides affects bioactivity and speed of
    degradation.
  • The biologic half-life
  • LH 20 minutes
  • FSH 3-4 hours
  • hCG 24 hours

7
FSH, LH, HCG
  • The protein dimer contains 2 polypeptide units,
    labeled alpha and beta subunits that are
    connected by two disulfide bridges
  • The alpha subunits of LH, FSH, TSH, and hCG are
    identical, and contain 92 amino acids
  • The beta subunits vary

8
Gn secretion
hypothalamus (arcuate nucleus and preoptic area)
(Gn-RH pulses)
pituitary gland
Gn
feed-back
ovary
  • estrogens

9
Estradiol negative feed-back
10
Pituitary gland embryology
11
Pituitary gland
by diencephalon (infundibulum)
by Rathke pouch (mouth)
12
Pituitary portal system
13
Pituitary gland histology
FSH LH TSH ACTH
HPRL
GH
14
Gn mode action
  • membrane receptors
  • Adenilcyclasi activation
  • activate a PtdIns
  • (phosphatidylinositol)-calcium second messenger
    system

15
Gn mode of action
(Index Resistance)
  • uterine blood flow
  • increases the uterine blood flow during the
    early luteal phase, a periimplantation stage

16
Gn mode of action
  • increase in the number of receptor in preparation
    for ovulation
  • After ovulation, the luteinized ovary maintains
    LH-R-s that allow activation in case there is an
    implantation

17
receptors activation
  • binding LH to the external part of the membrane
    spanning receptor
  • with LH attached, the receptor shifts
    conformation and thus
  • mechanically activates the G protein
  • and activates the cAMP system
  • 1 receptor sites activated

The seven transmembrane a-helix structure of a G
protein-coupled receptor such as LHCGR
18
Gn-R expression
  • Its expression requires appropriate hormonal
    stimulation by FSH and estradiol
  • present on
  • granulosa cells
  • theca cells
  • luteal cells
  • interstitial cells

19
Extragonadal Gn-Rs
  • Gn-Rs have been found in
  • the uterus,
  • sperm,
  • seminal vesicles,
  • prostate,
  • skin,
  • breast,
  • adrenals,
  • thyroid,
  • neural retina,
  • neuroendocrine cells,
  • and (rat) brain.
  • physiologic role largely unexplored.

20
Gn action in ovary
  • follicular maturation
  • ovulation
  • luteal function

21
Gonadotropins avverse effects
  • OHSS
  • Ovarian volume increased
  • Multiple pregnancies
  • Gynecomastia

22
FSH in early follicular phase
FSH threshold FSH serum concentrations needed
to stimulate ovarian follicle growth (Brown 1978)
  • At the onset of the menstrual cycle, a cohort of
    small (25 mm) antral follicles is present in
    each ovary
  • This cohort will continue to grow in response to
    stimulation by FSH
  • a process referred to as follicle recruitment
  • The follicle with the highest sensitivity will
    benefit most from increasing FSH levels and will
    subsequently gain dominance (leader leader)

Scheele F, Schoemaker J. 1996 The role of
follicle-stimulating hormone in the selection of
follicles in human ovaries a survey of the
literature and a proposed model. Gynecol
Endocrinol. 105566.
Brown JB. 1978 Pituitary control of ovarian
function concepts derived from gonadotropin
therapy. Aust NZ J Obstet Gynaecol. 184754
23
FSH in early follicular phase
FSH concentrations reach a maximum in the early
follicular phase of the normal menstrual cycle
and decrease thereafter
  • not increase much during a normal ovulatory cycle
  • FSH concentrations only 1030 above the
    threshold level is sufficient to stimulate normal
    follicle development

Brown JB. 1978 Pituitary control of ovarian
function concepts derived from gonadotropin
therapy. Aust NZ J Obstet Gynaecol. 184754.
Messinis IE, Templeton AA. 1990 The importance
of follicle-stimulating hormone increase for
folliculogenesis. Hum Reprod. 5153156.
24
FSH in follicular phase
  • Stimulates
  • follicular growth,
  • granulosa cell aromatase activity,
  • induction of LH receptors on the granulosa cell
    membrane,
  • estradiol secretion

25
Aromatase
  • enzyme of the cytochrome P450 group
  • mediate androgens aromatization
  • producing estrogens
  • sexual development

26
FSH in late follicular phase
  • decrease
  • due to increased ovarian secretion of
  • E2
  • ß-inhibin

negative feedback at the hypothalamic-pituitary
level
Hotchkiss J, Knobil E. 1994 The menstrual cycle
and its neuroendocrine control. In Knobil E,
Neill JD, eds. The physiology of reproduction.
New York Raven Press 711750. Groome NP,
Illingworth PJ, OBrien M, et al. 1996
Measurement of dimeric inhibin B throughout the
human menstrual cycle. J Clin Endocrinol Metab.
8114011405.
27
blood
  • Granulosa Cell
  • Thecal Cell

LH
FSH
Basement Membrane
cholesterol
R
CYP11
cAMP
E2
pregnenolone
  • R

CYP17
Protein Kinase A
17-OH-P
17ßHSD
CYP17
E1
DHEA
cAMP
P4
3ßHSD
Protein kinase
P450
Aldost
A
A
Cortisol
Steroidogenesis
28
FSH follicular decreasing
  • strict relationship with dominant follicle
    development
  • As a consequence, other recruited follicles lack
    sufficient stimulation by FSH and enter atresia

Zeleznik AJ, Hutchison JS, Schuler HM. 1985
Interference with the gonadotropin-suppressing
actions of estradiol in macaques overrides the
selection of a single preovulatory follicle.
Endocrinology. 117991999.
Schipper I, Hop J and Fauser B The
Follicle-Stimulating Hormone (FSH)
Threshold/Window Concept Examined by Different
Interventions with Exogenous FSH during the
Follicular Phase of the Normal Menstrual Cycle
Duration, Rather Than Magnitude, of FSH Increase
Affects Follicle Development. The Journal of
Clinical Endocrinology Metabolism Vol. 83, No.
4 1292-1298
29
FSH follicular decreasing
  • Apparently, the maturing dominant follicle
    requires less FSH to continue its growth.
  • Its due to up-regulated FSH-sensitivity of
    leading follicle for
  • induction of locally various growth factors
    (IGF-I, AMH, inibina B, leptina, ICAM-1, VCAM-1,
    VEGF)
  • induction of LH receptors that enhance FSH
    sensitivity
  • Erickson GF. 1996 The ovarian connection. In
    Adashi EY, Rock JA, Rosenwaks Z, eds.
    Reproductive endocrinology, surgery, and
    technology. Philadephia Lippincott-Raven
    11411160.

30
(No Transcript)
31
FSH in late luteal phase
  • At the end of the luteal phase, there is a slight
    rise in FSH that seems to be of importance to
    start the next ovulatory cycle
  • a cohort of small antral follicles is prevented
    from undergoing atresia and is stimulated for
    further development

Hodgen GD. 1982 The dominant ovarian follicle.
Fertil Steril. 38281300
32
LH mode action
  • With the rise in estrogens, LH receptors are also
    expressed on the maturing follicle
  • estrogen rise leads via the hypothalamic
    interface to the positive LH feed-back effect,
    a release of LH over a 24-48 hour period
  • This 'LH surge' triggers ovulation
  • LH is necessary to maintain luteal function (P4)
    for the first two weeks
  • LH supports thecal cells in the ovary that
    provide androgens and hormonal precursors for
    estradiol production
  • In case of a pregnancy luteal function will be
    further maintained by the action of hCG (a
    hormone very similar to LH) from the newly
    established pregnancy

33
FSH gene
  • a-chain gene
  • locate in arme 6p21.1-23
  • ß-chain gene
  • locate in 11p13 only in gonadotrope cells of
    pituitary gland
  • increased by Gn-RH and activine
  • decreased by inhibine

34
Deficient gonadotropins level
  • hypogonadism and amenorrhoea
  • Kallmann syndrome
  • Hypothalamic suppression
  • Hypopituitarism
  • Eating disorder (leptine)
  • Hyperprolactinemia
  • Gonadotropin deficiency
  • Gonadal suppression therapy
  • GnRH antagonist
  • GnRH agonist (downregulation)

35
LH-R abnormalities
  • in females can lead to infertility
  • masculinization
  • In 46, XY pseudohermaphroditism,
  • hypospadias
  • micropenis

Antibodies to LH-R can interfere with LH-R
activity
36
High Gonadotropin levels
Persistently high LH levels are indicative of
situations where the normal restricting feedback
from the gonad is absent, leading to a pituitary
production of both LH and FSH.
  • Premature menopause
  • Gonadal dysgenesis, Turner syndrome
  • Castration
  • Swyer syndrome
  • Polycystic Ovary Syndrome
  • Certain forms of CAH
  • Testicular failure

typical in the menopause
37
FSH in COH
  • multiple follicle development is induced by
    elevating FSH concentrations far above the
    threshold
  • By starting with a lower dose of gonadotropins
    and stepwise small increments, chances of
    inducing monofollicular growth should increase
    with a concomitant reduction of complications
    (step-up protocol)
  • However, these stimulation protocols are
    characterized by FSH concentrations remaining
    above the threshold

Polson DW, Mason HD, Saldahna MBY, Franks S. 1987
Ovulation of a single dominant follicle during
treatment with low-dose pusatile follicle
stimulating hormone in women with polcystic ovary
syndrome. Clin Endocrinol (Oxf). 26205212.
White DM, Polson DW, Kiddy D, et al. 1996
Induction of ovulation with low-dose
gonadotropins in polycystic ovary syndrome an
analysis of 109 pregnancies in 225 women. J Clin
Endocrinol Metab. 8138213824.
38
FSH gate
  • the "FSH-gate" or "FSH-window" concept has been
    proposed, which adds the element of time to the
    FSH threshold theory and emphasizes the
    significance of a transient increase in FSH above
    the threshold level for single dominant follicle
    development
  • Moreover, step-down dose regimen COH, has proven
    successful in reducing the incidence of multiple
    follicle development

Baird DT. 1987 A model for follicular selection
and ovulation lessons from superovulation. J
Steroid Biochem. 271523
van Santbrink EJP, Donderwinkel PFJ, van
Dessel HJHM, Fauser BCJM. 1995 Gonadotrophin
induction of ovulation using a step-down dose
regimen single-centre clinical experience in 82
patients. Hum Reprod. 1010481053
39
FSH window
  • the FSH window concept has been proposed,
    stressing the significance of the (limited)
    duration of FSH elevation above the threshold
    level
  • rather than the height of the elevation of FSH
    for single dominant follicle selection

Fauser BCJM, van Heusden AM. 1997 Manipulation of
human ovarian function physiological concepts
and clinical consequences. Endocr Rev. 1871106.
40
Gn dosage
  • For assisted reproductive technology procedures,
    the usual initial dose is 150 IU to 225 IU daily
    for 5 days.
  • The dose is then adjusted according to response
    and is usually continued for 6 to 12 days.
  • When an adequate response is achieved, this
    medication is stopped and another medication,
    hCG, is given to induce ovulation.

41
FSH initial doses
  • patients age
  • basal FSH
  • PCOS

42
HCG
  • HCG
  • pregnant women urine
  • made by the placenta
  • LH-activity like
  • gt half-life LH (4 h vs. 15 min)

Gonasi fl i.m. 1000, 2000, 5.000 UI
43
hCG in normal pregnancy
44
HCG
  • It is heterodimeric glycoprotein
  • a subunit identical to LH, FSH, TSH
  • ß subunit unique to hCG
  • 92 152 amino acids

45
HCG mode action
  • interacts with the LHCG receptor
  • Follicle rupture induction
  • maintenance of the corpus luteum during the
    beginning of pregnancy,
  • causing it to secrete P4
  • meiosis restarting

46
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com